Heart failure & cardiomyopathiesCohort study

Impact of implantable cardioverter-defibrillators on waitlist outcomes in children with ventricular assist devices

Heart RhythmPublished

  • propensity score matching
  • Scientific Registry of Transplant Recipients data (2010-2024)
  • cause-specific hazard models

Authors' conclusion

In a national cohort of pediatric VAD patients awaiting heart transplantation, there was no difference found in mortality, clinical deterioration, and rate of transplantation in patients with ICDs compared with those without.

Study context

Population
Pediatric VAD patients (aged <18 years) listed for primary heart-alone transplantpediatric VAD patients listed for heart transplant, 79 (6.3%) had implantable cardioverter-defibrillator (ICDs)
Participants
1,263 patients
Exposure
pediatric VAD patients with and without ICDs
  • ICDn = 79

Main finding

Waitlist mortality

Hazard ratio

1.1

95% CI 0.40–2.5

P = 0.76

ICD vs non-ICD
hazard ratio 1.1 (95% CI 0.40–2.5); P = 0.76

As reported in the abstract

Observational data: associations, not effects.

Further findings

Outcomehazard ratio (95% CI)P value
Likelihood of transplant · matched1.2 (0.93–1.5)P = 0.17

Baseline characteristics

VAD type: left VAD
83%
VAD type: bi-VAD
15%
VAD type: right VAD
2.5%
Age at listing, ICD vs non-ICD
15 vs 5 years; P < .0001
Amiodarone use, ICD vs non-ICD
56% vs 13%; P = .0002
Cardiac output, ICD vs non-ICD
3.9 vs 2.8 L/min; P = .0014
Listed as United Network for Organ Sharing status 1A, ICD vs non-ICD
84% vs 92%; P = .015
No significant differences in race, underlying diagnosis, VAD type, inotrope use, ventilator use, or extracorporeal membrane oxygenation use

Original publication

Impact of implantable cardioverter-defibrillators on waitlist outcomes in children with ventricular assist devices. Heart Rhythm. Published 24 June 2026. doi:10.1016/j.hrthm.2026.06.016

Summarised from the published abstract; every number is checked against it